Serum Institute of India – Asian Scientist Magazine

serum institute of india

Cipla Launches Hepatitis B Vaccine In India

Cipla’s hepatitis B vaccine can prevent 95 percent of the recipients from developing a chronic infection, protecting them for decades.

Pharma

Cipla To Distribute Nasal Flu Vaccine In India

Cipla will market SII's NasovacS vaccine, a painless influenza vaccine that can boost herd immunity.

Pharma

Serum Institute of India Acquires Rights To German TB Vaccine

The Serum Institute of India has announced plans to take a promising new tuberculosis vaccine, developed in Germany, into the clinic.

Features

The WHO Dealmakers: Sending Vaccine Technology To The Third World

Empowering countries to make their own vaccines may sound like a herculean task, but it is all in a day's work for the Technology Transfer Initiative team at the World Health Organization.

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Every year, Asian Scientist Magazine publishes Asian Scientist 100, a carefully curated list of the best and brightest researchers and leaders in SETM in Asia. This year we complete a decade of doing so.
Learning From Environmental Defenders

Drawing on traditional knowledge systems, environmental researchers and policymakers in Asia are working with indigenous communities to design better strategies for environmental conservation.
The Equalizers

Across Asia, people with disabilities are breaking physical and social barriers to STEM fields, opening the way for others.

Cipla Launches Hepatitis B Vaccine In India

Cipla To Distribute Nasal Flu Vaccine In India

Serum Institute of India Acquires Rights To German TB Vaccine

The WHO Dealmakers: Sending Vaccine Technology To The Third World

EDITOR’S PICK

10 Years Of Celebrating Asia’s Researchers

Learning From Environmental Defenders

The Equalizers